Product Information

DULOXETINE HCL DR 60 MG CAP is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1293 per EA under NDC 82009017310. Its NADAC has been published 49 times since Sep 17, 2025.

FDA first approved this application on Jan 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DULOXETINE HCL DR 60 MG CAP

Duloxetine
$0.1293per EA

Strength

60 mg/1

NDC

82009017310

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DULOXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208706

FDA Approved

1/6/2017

TE Code

AB

On Market Since

7/1/2025

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for DULOXETINE HCL DR 60 MG CAP has been published 49 times since Sep 17, 2025, and over the history we have for it it has risen 36.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1293 per EA
All-time high$0.1306 (Jun 10, 2026)
All-time low$0.0929 (Nov 19, 2025)
52-week high$0.1306
52-week low$0.0929
Median price$0.1024
Average price$0.1095
Largest weekly change+11.0% (Mar 18, 2026)
Weeks tracked49
Tracking sinceSep 17, 2025

Price History

1W

+0.2%

1M

+0.2%

3M

-1.0%

6M

+26.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

+36.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DULOXETINE HCL DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 60 MG CAP, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1293 per EA (NDC 82009017310), effective Aug 19, 2026.

How has the price of DULOXETINE HCL DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DULOXETINE HCL DR 60 MG CAP has risen 36.3%. It has been tracked across 49 weekly CMS publications since Sep 17, 2025.

What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 60 MG CAP?

Since Sep 17, 2025, the NADAC for DULOXETINE HCL DR 60 MG CAP has ranged from a low of $0.0929 (Nov 19, 2025) to a high of $0.1306 (Jun 10, 2026), with a median of $0.1024 per EA.

Are there cheaper alternatives to DULOXETINE HCL DR 60 MG CAP?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DULOXETINE HCL DR 60 MG CAP, is $0.1072 per EA — about 17% below DULOXETINE HCL DR 60 MG CAP.

Who manufactures DULOXETINE HCL DR 60 MG CAP?

DULOXETINE HCL DR 60 MG CAP (NDC 82009017310) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.